Health
Scientists identify synthetic mini-antibody to combat COVID-19 – Science Codex
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike protein binds ACE2 using three finger-like protrusions, called the receptor binding domains (RBDs). Blocking the RBDs therefore has the potential to stop the virus from entering human cells. This can be done using antibodies.
Nanobodies, small antibodies found in camels and llamas, are promising as…
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General23 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News16 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News13 hours agoTips to improve engagement – Proctor